Taiwan FDA registration bd8fc49c2dbf565dc3da0ada1df70312
Abbott multiple drug concentration quality control solution
TW: 亞培多重藥物濃度品管液
Taiwan·Risk Class 2·MICROGENICS CORPORATION·Registered Sep 18, 2020 – Sep 18, 2025ExpiredRegistration details
- Analysis ID
- bd8fc49c2dbf565dc3da0ada1df70312
- Customs Code
- DHA05603356001
Company information
- Manufacturer
- MICROGENICS CORPORATION
- Manufacturer Country
- United States
- Authorized Representative
- ABBOTT LABORATORIES SERVICES LLC TAIWAN BRANCH (U.S.A.)
Product details
- Intended Use
- This product is used to perform the quality management of the Apex benzene diazo base salt serum test set and the Apex tricyclic antidepressant test set on the Alinity c analyzer.
- Product Type (Level 1)
- A Clinical chemistry and clinical toxicology
- Product Type (Level 2)
- A.1660 Quality control materials (analytical and non-analytical)
- Import Information
- QMS/QSD;; 輸入
Dates and status
- Registration Date
- Sep 18, 2020
- Expiry Date
- Sep 18, 2025
About this record
Access comprehensive regulatory information for Abbott multiple drug concentration quality control solution in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number bd8fc49c2dbf565dc3da0ada1df70312 and manufactured by MICROGENICS CORPORATION. The authorized representative in Taiwan is ABBOTT LABORATORIES SERVICES LLC TAIWAN BRANCH (U.S.A.).
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Free DatabasePowered by Pure Global AI89,000+ Devices